703 - Carcinogenesis and Tumor Cell Biology
Semester I; 3 credits.
Prerequisites: Oncology 401 or equivalent, organic chemistry, biochemistry, cell biology, virology, or consent of instructor.
Instructors: Chris Bradfield (course organizer), Caroline Alexander, Paul Lambert, Jeff Ross, Wei Xu. Associates: M. Albertini, W. Bushman, Y. Matloub, D. McNeel, A. Moser, A. Roopra, R. Tibbetts.
Fall 2007 Course Information
Meeting time/location: 12:05 PM
Monday, Wednesday, and Friday
Room 125 McArdle Laboratory for Cancer Research
Faculty
Chris Bradfield (course organizer)
213A McArdle
telephone: 262-2024
bradfield@oncology.wisc.edu
Paul Lambert
710A McArdle
telephone: 262-8533
lambert@oncology.wisc.edu
Caroline Alexander
819A McArdle
telephone: 265-5182
alexander@oncology.wisc.edu
Jeff Ross
625 McArdle
telephone: 262-3413
ross@oncology.wisc.edu
Wei Xu
421A McArdle
telephone: 265-5540
wxu@oncology.wisc.edu
Teaching Approach
This course provides a survey of the molecular mechanisms underlying cancer. The course is taught primarily through the description of experiments that provide new insights in cancer biology. Specific cancers will be emphasized and used to demonstrate central themes in cancer biology. There is a heavy reliance upon reading and understanding primary scientific literature. While the classes are designed primarily around faculty lectures, student participation in class is expected. The course grade is primarily based upon the students' performance in class and their written responses to take home assignments.
Preparation for Each Class
Written material important to the course will be handed out in class. Students should read all handouts for a specific lecture before arriving in class. This includes the background information as well as assigned primary papers. The significance, qualifications, and implications of the studies described in these assigned papers will be discussed in class. The faculty will sometimes ask students to summarize specific experiments described in the assigned papers. Students should be prepared to provide a short description of: (a) the question being asked; (b) the approach used to answer the question; (c) the results obtained; (d) the authors' conclusions drawn from their experiment; and (e) an individual commentary on the value and significance of the experiment.
Exams/Assignments
There are no formal in-class examinations. Instead, students are provided periodic (weekly or more frequent) take-home assignments that involve addressing questions pertaining to a particular reading assignment. Each student is expected to work individually on these assignments. Assignments are to be handed in at the beginning of the class period on the day they are due. Graded assignments will be handed back to students and issues surrounding the answers discussed in class. The goal of these assignments are to foster an appreciation of the primary literature relating to a particular topic and to help students learn to synthesize new ideas and design experiments to test/distinguish between hypotheses.
Help
Students who need any assistance during the course can contact Dr. Bradfield directly or speak with any of the other faculty at the beginning or end of class.
Oncology 703 – Fall 2007
Class Syllabus
Date |
Lecturer |
Title |
September 5, 2007 |
Bradfield |
Introduction/Env and Cancer |
September 7, 2007 |
Lambert |
Insertional Mutagenic Retroviruses |
September 10, 2007 |
Lambert |
TBA |
September 12, 2007 |
Lambert |
EBV and Burkitt's Lymphoma |
September 14, 2007 |
Lambert |
Kaposi's Sarcoma/Herpes Virus |
September 17, 2007 |
Lambert |
Hepatitis B Virus and Liver Cancer |
September 19, 2007 |
Lambert |
Tumor Immunology I |
September 21, 2007 |
Lambert |
Adenovirus/SV40 and Tumor Suppressors |
September 24, 2007 |
Lambert |
Human Papillomavirus and Cervical Cancer |
September 26, 2007 |
Lambert |
Human Papillomavirus and Cervical Cancer |
September 28, 2007 |
Lambert |
TBA |
October 1, 2007 |
Lambert (Albertini) |
Cancer Vaccines |
October 3, 2007 |
Lambert (McNeel) |
Tumor Immunology II |
October 5, 2007 |
Bradfield |
Liver Cancer |
October 8, 2007 |
Bradfield |
Chemical Carcinogenesis/Metabolism |
October 10, 2007 |
Bradfield |
Chemical Carcinogenesis/Alkylation |
October 12, 2007 |
Bradfield (Tibbetts) |
DNA Repair |
October 15, 2007 |
Bradfield (Tibbetts) |
DNA Repair |
October 17, 2007 |
Bradfield (Tibbetts) |
DNA Repair |
October 19, 2007 |
Xu |
Cancer Epigenetics I: Introduction & DNA Methylation |
October 22, 2007 |
Xu |
Cancer Epigenetics II: Histone Modifications & Chromatin Remodeling |
October 24, 2007 |
Xu |
Cancer Epigenetics III: Non-coding RNA & Current Technologies |
October 26, 2007 |
Ross |
Leukemia I: Origin and Development |
October 29, 2007 |
Ross (Matloub) |
Childhood Leukemia |
October 31, 2007 |
Ross |
Leukemia II: Tumor Initiating Cells |
November 2, 2007 |
Ross |
Leukemia III: Philadelphia Chromosome |
November 5, 2007 |
Ross |
Leukemia IV: Cell Differentiation and Tumor Therapy |
November 7, 2007 |
Ross |
Leukemia V: Oncogenesis and the Microenvironment |
November 9, 2007 |
Ross |
Breast Cancer I |
November 12, 2007 |
Ross |
Breast Cancer II: Estrogen, SERMS and Aromatase |
November 14, 2007 |
Ross |
Breast Cancer III: Experimental Models |
November 16, 2007 |
Ross |
Breast Cancer IV: Genetics |
November 19, 2007 |
Ross (Bushman) |
Prostate Cancer I |
November 21, 2007 |
Ross (Bushman) |
Prostate Cancer II |
November 23, 2007 |
Thanksgiving Recess – No Class |
|
November 26, 2007 |
Alexander |
Cancer: A Genetic Disease? |
November 28, 2007 |
Alexander |
Mouse Models of Human Tumors: Intro |
November 30, 2007 |
Alexander |
Mouse Models of Human Tumors: History |
December 3, 2007 |
Alexander |
Mouse Models of Human Tumors: Future |
December 5, 2007 |
Alexander |
Colorectal Cancer: Intro |
December 7, 2007 |
Alexander |
Colorectal Cancer: FAP |
December 10, 2007 |
Alexander (Moser) |
Susceptibility Genes: Discovery of Mom1 |
December 12, 2007 |
Alexander |
Colorectal Cancer: HNPCC |
December 14, 2007 |
Alexander (Roopra) |
Metabolism and Cancer: Caloric Restriction |